Giancarlo Castaman

Medical Director
Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy

Presentation(s):

• LB 01.2 - Concizumab Prophylaxis in Patients With Haemophilia A or B With Inhibitors: Efficacy and Safety Results From the Primary Analysis of the Phase 3 explorer7 Trial

  Sunday, July 10, 2022
  3:00 PM – 3:15 PM

• PB0193 - Dose optimization for prophylaxis using a pharmacokinetic model for factor IX products in severe hemophilia B

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB1123 - Annualised Bleeding Rate and Joint Health: Second Interim Analysis of the Real-world HEM-POWR Study Evaluating the Effectiveness of Damoctocog Alfa Pegol in Patients With Haemophilia A

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1188 - Efficacy and safety of eptacog beta for resolution of spontaneous versus traumatic bleeding episodes in patients with hemophilia A or B with inhibitors

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM